Item 5.07 Submission of Matters to a Vote of Security Holders.
On December 30, 2021, Pressure BioSciences, Inc. (the "Company") held a special
meeting in lieu of the annual meeting of stockholders (the "Meeting"). At the
Meeting, the stockholders voted on the following proposals described in detail
in the Company's definitive proxy statement for the Meeting filed with the
Securities and Exchange Commission on November 19, 2021. As of the record date
for the Meeting, there were 7,456,391 shares of the Company's common stock, par
value $0.01 per share, issued and outstanding and entitled to one vote for each
share held. The holders of 55.07% of the Company's shares of common stock
outstanding (4,105,963) submitted votes by proxy or in person at the Meeting,
constituting a quorum.
Proposal 1 - Elect two directors as Class I Directors until the 2024 Annual
Meeting of Stockholders. The election of the directors was approved as follows:
Shares voted
Nominee For Against Withhold Broker Non-Votes
Jeffrey N. Peterson 2,472,894 N/A 84,187 1,548,882
Michael S. Urdea 2,507,006 N/A 50,075 1,548,882
Proposal 2 - Ratify the appointment of MaloneBailey LLP as the Company's
independent auditor for fiscal year 2021. The ratification of the appointment of
MaloneBailey LLP as the Company's independent auditor for fiscal year 2021 was
approved as follows:
Shares voted
For 4,084,151
Against 930
Abstain 20,882
Broker Non-Votes 0
Proposal 3 - Ratify the approval of the Company's 2021 Equity Incentive Plan.
The ratification of the approval of the Company's 2021 Equity Incentive Plan was
adopted as follows:
Shares voted
For 2,396,474
Against 125,594
Abstain 35,013
Broker Non-Votes 1,548,882
© Edgar Online, source Glimpses